This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Diabetes
Diabetes
European Commission approves Jardiance® (empagliflozin) for Type 2 Diabetes
First patient recruited into global study to help improve quality of life for patients with diabetes
CHMP recommends empagliflozin for approval for type 2 diabetes
Poll conducted with primary care physicians about type 2 diabetes management
Sanofi announces new Phase III results for investigational new insulin U300
Ryzodeg® offers improved glycaemic control
IDegLira demonstrates superior glycaemic control and weight loss
Novo Nordisk and Roche Diabetes Care join forces to make insulin pump therapy simpler
Diabetes surge hits every nation
Call for action to improve standards of care for people living with psoriasis in Europe
The role of pharmacists in diabetes care
New data for Novartis drug Lucentis®
« Previous
1
…
4
5
6
7
8
…
26
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: